Notice NOT-HS-18-006 from the NIH Guide for Grants and Contracts

Notice NOT-FD-18-007 from the NIH Guide for Grants and Contracts

Notice NOT-DA-18-007 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-147 from the NIH Guide for Grants and Contracts

Notice NOT-DE-18-011 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-FD-18-006 from the NIH Guide for Grants and Contracts. The intended outcome of this program is to advance efforts to improve and develop state drug residue prevention programs. It is necessary to provide assistance to state drug residue programs that need a stronger foundation to promote the prevention of illegal drug residues in animal derived foods through educational outreach and training. This program is intended to ensure drug residue prevention programs are developed to protect consumer exposure to drug residues in the edible products of food animals and support activities related to drug residue prevention. In addition, these awards will assist state agencies to better direct their programs to reduce the outcomes of illegal drug residues in animal derived foods. This cooperative agreement program (CAP) will focus on outreach, education and training. In addition, grantees will focus on performing targeted on-site assessments related to drug residue violations and best practice visits to industry and individuals to communicate proper drug use and promote effective management practices for drug residue prevention.

$66,706 - $90,532 pa Level A (plus 9.5% employer superannuation): Monash University Human Resources: Opportunity to join the Epigenetics and Reprogramming Laboratory led by Associate Professor Jose M. Polo at Monash University. Clayton, Monash (AU)

Notice NOT-OD-18-148 from the NIH Guide for Grants and Contracts

Notice NOT-NS-18-017 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-150 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-CA-18-020 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but that now may be open to investigations using new strategies and recent technical advances. The current issuance of the PQ Initiative includes an updated set of 12 PQs. Each research project proposed in response to this FOA must be focused on addressing one particular research problem defined by one specific PQ selected from the list. Projects proposed to address specific PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the scientific focus of the specific PQ chosen.

Funding Opportunity RFA-CA-18-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support research projects designed to solve specific problems and paradoxes in cancer research identified by the National Cancer Institute (NCI) Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention. Some of these "Provocative Questions" (PQs) stem from intriguing but older, neglected observations that have never been adequately explored. Other PQs are built on more recent findings that are perplexing or paradoxical, revealing important gaps in current knowledge. Finally, some PQs reflect problems that traditionally have been thought to be intractable but that now may be open to investigations using new strategies and recent technical advances. The current issuance of the PQ Initiative includes an updated set of 12 PQs. Each research project proposed in response to this FOA must be focused on addressing one particular research problem defined by one specific PQ selected from the list. Projects proposed to address specific PQs may use strategies that incorporate ideas and approaches from multiple disciplines, as appropriate. Transdisciplinary projects are encouraged as long as they serve the scientific focus of the specific PQ chosen.

Notice NOT-DA-18-009 from the NIH Guide for Grants and Contracts

Notice NOT-AT-18-008 from the NIH Guide for Grants and Contracts

Notice NOT-OD-18-146 from the NIH Guide for Grants and Contracts

Bachelor's degree in a science required with a focus on Biology, Microbiology, Biochemistry or related field....
From University of Wisconsin–Madison - Fri, 09 Mar 2018 00:58:41 GMT - View all Madison, WI jobs

Negotiable: Paramount Recruitment: Software Engineer - Bioinformatics A superb new opportunity has become available for a talented Software Developer to work with a growing Biotech based in Cambridge. Cambridge, England

Notice NOT-OD-18-149 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: Bioinformatics Engineer / Data AnalystLocation:Heidelberg, GermanyStaff Category:Staff MemberContract Duration:3 years (renewable)Grading:4, 5 or 6, depending on experience and qualificationsTClosing Date:15 April 2018Reference Number:HD_01272Job Descrip Germany (DE)

Funding Opportunity RFA-AI-18-002 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to participate in the NIAID Autoimmunity Centers of Excellence (ACE), a cooperative network intended to improve the understanding, prevention, and treatment of autoimmune diseases (www.autoimmunitycenters.org). The ACE was founded on the premise that collaborations among basic and clinical scientists can accelerate both fundamental and applied research. The ACE combines Basic and Clinical research programs. This FOA solicits applications for the Basic research program; a companion FOA solicits applications for the Clinical research program. Members of the Basic research program will conduct innovative studies of human autoimmunity within Principal, Pilot, and Collaborative Projects. Members of the Basic and Clinical ACE will work together to design and conduct studies of autoimmune disease pathogenesis and mechanisms of action of immune-modulating agents being tested in ACE clinical trials.